Rapport Therapeutics, Inc. (RAPP)
CIK 2012593 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Rapport Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 9, 2026 | 4 | 0001193125-26-386436 |
| Aug 26, 2026 | 4 | 0001193125-26-368244 |
| Aug 26, 2026 | 4 | 0001193125-26-368285 |
| Aug 25, 2026 | 144 | 0001950047-26-008670 |
| Aug 24, 2026 | 144 | 0001950047-26-008594 |
| Aug 20, 2026 | 4 | 0001193125-26-359189 |
| Aug 19, 2026 | 144 | 0001950047-26-008426 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001193125-26-352285 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001172661-26-003693 |
| Aug 12, 2026 | 4 | 0001193125-26-346995 |
| Aug 12, 2026 | SCHEDULE 13G/A | 0001562230-26-000114 |
| Aug 5, 2026 | 8-K | 0001193125-26-333853 |
| Aug 5, 2026 | 10-Q | 0001193125-26-333862 |
| Jul 29, 2026 | 4 | 0001193125-26-323637 |
| Jul 15, 2026 | 4 | 0001193125-26-304786 |
| Jul 1, 2026 | 4 | 0001193125-26-292546 |
| Jul 1, 2026 | 4 | 0001193125-26-292519 |
| Jun 30, 2026 | 144 | 0001950047-26-006648 |
| Jun 29, 2026 | 144 | 0001958244-26-000411 |
| Jun 10, 2026 | 4 | 0001193125-26-266147 |
| Jun 10, 2026 | 4 | 0001193125-26-266095 |
| Jun 10, 2026 | 8-K | 0001193125-26-265841 |
| Jun 10, 2026 | 4 | 0001193125-26-266099 |
| Jun 10, 2026 | 4 | 0001193125-26-266090 |
| Jun 10, 2026 | 4 | 0001193125-26-266129 |